Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Koichi Ishii is active.

Publication


Featured researches published by Koichi Ishii.


Development Genes and Evolution | 1990

Mesodermal induction in early amphibian embryos by activin A (erythroid differentiation factor)

Makoto Asashima; Hiroshi Nakano; Shimada K; Kei Kinoshita; Koichi Ishii; Hiroshiro Shibai; Naoto Ueno

SummaryRecently the mesoderm-inducing effects of the transforming growth factor β (TGF-β) family of proteins have been widely examined. In an attemt to elucidate the functions of these proteins, porcine inhibin A and activin A (erythroid differentiation factor; EDF) were examined. Treatment of explants with activin A led to differentiation of mesodermal derivatives such as mesenchyme, notochord, blood cells and muscle, but inhibin A had a much lesser effect. The mesodermal differentiation induced by activin A was also comfirmed by analyses using a polyclonal antibody against muscle myosin. By indirect immunofluorescence analysis, the differentiation of muscle blocks was observed in the activin-A-treated explants, whereas no differentiation was observed in inhibin-A-treated and control explants. These findings confirm that this protein of the TGF-β family has mesoderm-inducing ability.


British Journal of Nutrition | 2009

Effects of safflower seed extract supplementation on oxidation and cardiovascular risk markers in healthy human volunteers

Naoto Koyama; Katsuya Suzuki; Yasushi Furukawa; Harumi Arisaka; Tetsuya Seki; Kanna Kuribayashi; Koichi Ishii; Eiji Sukegawa; Michio Takahashi

We previously demonstrated that safflower seed extract (SSE) and its major antioxidant constituents, serotonin hydroxycinnamic acid amides, suppressed LDL oxidation in vitro, decreased plasma autoantibody titres to oxidized LDL and attenuated atherosclerotic lesion formation in apoE-deficient mice. In this report, we examined whether SSE, rich in serotonin derivatives, could affect markers of oxidative stress, inflammation and aortic stiffness in healthy human subjects. Twenty Japanese male volunteers were studied at baseline, after 2.1 g SSE supplementation daily (providing 290 mg serotonin derivatives/d) for 4 weeks, and after a 4-week washout period. Significant reductions in circulating oxidized LDL, autoantibody titres to malondialdehyde-modified LDL, the soluble form of vascular cell adhesion molecule-1 (sVCAM-1), and urinary 8-isoprostane were observed after a 4-week intervention. Although there were no statistically significant differences in blood pressure or brachial-ankle pulse wave velocity (baPWV), an index of arterial stiffness, baPWV was lower than baseline in eleven of twenty subjects and was accompanied by a reduction in blood pressure. Statistically significant negative correlations were observed between the extent of initial cardiovascular risk markers (autoantibody titres, 8-isoprostane, sVCAM-1 and baPWV) and the effect of intervention. This suggested that individuals with elevated oxidative stress, inflammation, and/or arterial stiffness may receive more benefit from SSE supplementation.


Biochemical and Biophysical Research Communications | 1992

Isolation and identification of C-type natriuretic peptide in human monocytic cell line, THP-1

Yushiro Ishizaka; Kenji Kangawa; Naoto Minamino; Koichi Ishii; Satoshi Takano; Tanenao Eto; Hisayuki Matsuo

In a survey for unknown bioactive peptides in mammalian cell lines, we isolated peptides exhibiting a strong relaxant effect on chick rectum from a phorbol ester-supplemented culture medium of the human monocytic cell line, THP-1. The peptide was deduced to be a C-terminal 29-residue peptide derived from a human C-type natriuretic peptide (CNP) precursor. CNP mRNA was also detected in the THP-1 cells, and expression of CNP gene and CNP concentration in the culture medium was found to be highly augmented by the stimulation of phorbol ester. Production of CNP in THP-1 cells suggests that CNP also functions as a local regulator in the blood cell-vascular system, although CNP has previously been recognized as a neuropeptide functioning in the central nervous system.


Development Growth & Differentiation | 1990

Activities of Mesoderm‐Inducing Factors Secreted by Mammalian Cells in Culture1

Hiroshi Nakano; Kei Kinoshita; Koichi Ishii; Hiroshiro Shibai; Makoto Asashima

We have examined the activities of several mesoderm‐inducing factors contained in the culture fluids of phorbol ester (4beta‐phorbol 12‐myristate 13‐acetate;PMA)‐stimulated human cell lines. Mesoderm induction was assayed by examining the differentiation of mesoderm tissues reacted with presumptive ectoderm of the Cynops blastula. The assay system also examined erythroid differentiation activity (EDF activity) in order to test the relationship between mesoderm induction and activin A (EDF). Of 22 human cell lines examined, six strains were positive for both mesoderm‐inducing activity and EDF activity. Four strains showed only mesoderm inducing activity, and one showed only EDF activity. The remaining 11 strains showed neither activity. Therefore, most cell lines secreting mesoderm‐inducing activity also possessed EDF activity. Furthermore, culture fluid of a strain (K‐562) that exhibited both types of activities, was partially fractionated by DEAE‐Toyopearl column chromatography and examined in the same way. The fractions that showed the highest amount of EDF activity were coincident with those displaying mesoderm‐inducing activity. These results suggest that a number of PMA‐stimulated mammalian cell lines have the ability to secrete mesoderm‐inducing factors which are similar to activin A (EDF).


Journal of Agricultural and Food Chemistry | 2006

Serotonin Derivatives, Major Safflower (Carthamus tinctorius L.) Seed Antioxidants, Inhibit Low-Density Lipoprotein (LDL) Oxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice

Naoto Koyama; Kanna Kuribayashi; Tetsuya Seki; Katsunori Kobayashi; Yasufumi Furuhata; Katsuya Suzuki; Harumi Arisaka; Takashi Nakano; Yusuke Amino; Koichi Ishii


Archive | 1994

Peptide having antithrombotic activity and process for producing the same

Naoyuki Fukuchi; Hiroshi Yamamoto; Mitsuyo Nagano; Morikazu Kito; Akiko Tanaka; Koichi Ishii; Tsuyoshi Kobayashi; Ryota Yoshimoto


Archive | 1999

Substance with antithrombotic activity and method for detecting glycokallidin

Naoyuki Fukuchi; Fumie Futaki; Morikazu Kito; Seiichi Sato; Takayuki Kajiura; Yukitsugu Ono; Koichi Ishii; Akiko Tanaka; Junko Shinozaki; Yasuko Jojima


The Journal of Antibiotics | 1988

A novel naturally occurring carbapenem antibiotic, AB-110-D, produced by Kitasatosporia papulosa novo sp.

Yoshihiro Nakamura; Koichi Ishii; Eiji Ono; Masaru Ishihara; Toru Kohda; Yasunori Yokogawa; Hiroshiro Shibai


Archive | 2006

Composition for preventing atherosclerosis

Naoto Koyama; Kanna Kuribayashi; Koichi Ishii; Katsunori Kobayashi


Archive | 2006

Plant seed extract composition and process for producing the same

Naoto Koyama; Tetsuya Seki; Harumi Arisaka; Koichi Ishii

Collaboration


Dive into the Koichi Ishii's collaboration.

Researchain Logo
Decentralizing Knowledge